TriSalus Life Sciences, Inc.

MedTech Acquisition Corp, which traded under the ticker MTAC, was a blank-check company sponsored by MedTech Acquisition Sponsor, LLC and focused on the healthcare and life sciences sector. The SPAC completed its initial public offering in 2021 and subsequently entered into a definitive business combination agreement with TriSalus Life Sciences, Inc., a drug delivery company developing therapies for liver and pancreatic cancers. The 10-K filed with the SEC on March 3, 2022 covers the fiscal year during which the company was actively pursuing that transaction. The business combination ultimately closed later in 2022, transitioning the combined entity to an operating life sciences company. Sign up at SpacDesk for full filing history, sponsor profiles, and deal-stage analytics on MTAC and hundreds of other SPACs.